Enhanced Antibacterial Activity of Se Nanoparticles Upon Coating with Recombinant Spider Silk Protein eADF4(kappa 16) by Huang, T et al.
OR I G I N A L R E S E A R C H
Enhanced Antibacterial Activity of Se
Nanoparticles Upon Coating with Recombinant
Spider Silk Protein eADF4(κ16)
This article was published in the following Dove Press journal:
International Journal of Nanomedicine
Tao Huang 1,2
Sushma Kumari 2
Heike Herold 2
Hendrik Bargel 2
Tamara B Aigner2
Daniel E Heath 1
Neil M O’Brien-Simpson3
Andrea J O’Connor 1
Thomas Scheibel 2,4
1Department of Biomedical Engineering,
Melbourne School of Engineering,
University of Melbourne, Parkville, VIC
3010, Australia; 2Department for
Biomaterials, Faculty of Engineering
Science, University of Bayreuth, Prof.
Rüdiger Bormann Str. 1, Bayreuth 95447,
Germany; 3Melbourne Dental School and
the Bio21 Institute of Molecular Science
and Biotechnology, The University of
Melbourne, Parkville, VIC 3010,
Australia; 4Bavarian Polymer Institute
(BPI), Bayreuth Center for Material
Science and Engineering (BayMAT),
Bayreuth Center for Colloids and
Interfaces (BZKG), Bayreuth Center for
Molecular Biosciences (BZMB),
University of Bayreuth, Bayreuth 95447,
Germany
Purpose: Selenium nanoparticles (Se NPs) are promising antibacterial agents to tackle the
growing problem of antimicrobial resistance. The aim of this study was to fabricate Se NPs
with a net positive charge to enhance their antibacterial efficacy.
Methods: Se NPs were coated with a positively charged protein – recombinant spider silk
protein eADF4(κ16) – to give them a net positive surface charge. Their cytotoxicity and
antibacterial activity were investigated, with negatively charged polyvinyl alcohol coated Se
NPs as a control. Besides, these eADF4(κ16)-coated Se NPs were immobilized on the spider
silk films, and the antibacterial activity of these films was investigated.
Results: Compared to the negatively charged polyvinyl alcohol coated Se NPs, the posi-
tively charged eADF4(κ16)-coated Se NPs demonstrated a much higher bactericidal efficacy
against the Gram-negative bacteria E. coli, with a minimum bactericidal concentration
(MBC) approximately 50 times lower than that of negatively charged Se NPs. Cytotoxicity
testing showed that the eADF4(κ16)-coated Se NPs are safe to both Balb/3T3 mouse embryo
fibroblasts and HaCaT human skin keratinocytes up to 31 µg/mL, which is much higher than
the MBC of these particles against E. coli (8 ± 1 µg/mL). In addition, antibacterial coatings
were created by immobilising the eADF4(κ16)-coated Se NPs on positively charged spider
silk films and these were shown to retain good bactericidal efficacy and overcome the issue
of low particle stability in culture broth. It was found that these Se NPs needed to be released
from the film surface in order to exert their antibacterial effects and this release can be
regulated by the surface charge of the film, such as the change of the spider silk protein used.
Conclusion: Overall, eADF4(κ16)-coated Se NPs are promising new antibacterial agents
against life-threatening bacteria.
Keywords: Gram-positive, Gram-negative, E. coli, antibacterial film, cytotoxicity
Introduction
Bacterial infections are a major cause of chronic wounds and mortality.1 Currently
used antibiotics kill bacteria mainly targeting cell wall synthesis, translational
machinery, or DNA replication machinery.1 However, bacteria can develop resis-
tance to antibiotics by producing modified enzymes that decompose antibiotics,2
changing cell components to inhibit antibiotic interaction,3 and increase the expres-
sion of efflux pumps to excrete different types of antibiotics.4 In recent years,
excessive use of antibiotics has induced the rapid development of drug-resistant
bacteria.5 Bacteria resistant to all antibiotics (pandrug-resistant bacteria) have
already been reported.6 These multidrug-resistant bacteria have become a potential
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global public health threat. Therefore, new antibacterial
strategies are urgently needed to tackle the growing pro-
blem of these pandrug-resistant bacteria, the so-called
“superbugs”.
Nanoparticles (NPs) are considered to be promising
antimicrobial agents to kill antibiotic-resistant bacteria, as
most of the antibiotic resistance mechanisms have very
limited effect on NPs.1 Several types of NPs have been
explored for antimicrobial applications, such as Ag NPs,7
Au NPs,8 Se NPs,9 Pd NPs,10 Ti2O NPs,
11 CuO NPs,12 and
so on. Among these NPs, the antibacterial Se NPs have
attracted increasing attention, with studies showing pro-
mising antimicrobial activities against bacteria and
fungi13–16 as well as the ability to disrupt biofilms.17
Unlike Ag, Au, Pd and Ti, selenium is a trace element in
the human body.18 It is an important component in at least
25 selenoenzymes and a cofactor for glutathione peroxi-
dases and thioredoxin reductases.19 Ag NPs, as the most
widely researched nanoparticles for antibacterial applica-
tions exhibit excellent antibacterial activity, but at the
same time, show high toxicity to human cell lines.20,21
Our previous work compared the cytotoxicity and antibac-
terial activity of chitosan/polyvinyl alcohol scaffolds
loaded with either Ag NPs or Se NPs. Both types of
scaffolds showed antibacterial activity, but the scaffolds
decorated with Se NPs were more cytocompatible with
fibroblasts than the Ag NPs loaded scaffolds.22 Recent
reports from our group9,23 and others24,25 showed that
negatively charged Se NPs showed strong antibacterial
effects against Gram-positive bacteria but were less effec-
tive against Gram-negative bacteria. The electrostatic
attraction between positively charged nanoparticles and
the negatively charged membranes of bacterial cells
plays an important role in the antibacterial activity of
nanoparticles.26,27 Since the membrane of Gram-negative
bacteria is generally more negatively charged than that of
Gram-positive bacteria,28,29 they have been observed to be
more sensitive to positively charged nanoparticles.28
Therefore, positively charged nanoparticles have been
explored for effective antibacterial applications.30–32 For
example, Liu et al reported that positively charged Ag NPs
showed a much lower minimum inhibitory concentration
(MIC) than negatively charged Ag NPs against the Gram-
positive bacteria Bacillus subtilis, the Gram-negative bac-
teria E. coli, and the pathogenic yeast Candida albicans.33
Thus, modifying the surface of Se NPs with positive
charge is a promising approach to improve the antibacter-
ial activity of Se NPs against Gram-negative bacteria.
However, most previous studies on antibacterial Se NPs
have used negatively charged coatings to stabilize the
particles.9,23-25,34 One study that did use a positively
charged chitosan coating on Se NPs did not find that it
improved their antibacterial efficacy over negatively
charged polyvinyl alcohol (PVA)-coated Se NPs. In fact,
the chitosan coated Se NPs were found to show much
higher MIC than the PVA coated Se NPs against both
S. aureus (500 µg/mL vs 125 µg/mL) and E. coli (500
µg/mL vs 250 µg/mL).35 This unexpected result may be
due to different sized NPs being used with the different
coatings (195 nm for the chitosan coated Se NPs vs 136
nm for the PVA coated Se NPs). Importantly, size is one
key factor influencing the uptake of NPs by cells in gen-
eral and the antibacterial efficacy of Se NPs in particular.23
Another factor could be surface charge, as a positively
charged surface coating has been shown to increase the
uptake of Se NPs by cancer cells.36 Thus, the influence of
positive charge on cytotoxicity and antibacterial activity of
Se NPs still needs to be investigated.
Several synthetic and biopolymers with positive charge
have been previously used as coatings of inorganic nanopar-
ticles to enhance the antimicrobial activity, such as branched
polyethyleneimine (PEI),37 poly-allylamine hydrochloride
(PAH),38 chitosan39,40 and oligochitosan.41 The PEI has dis-
advantages including toxicity and nonbiodegradability.42
PAH has high toxicity toward various mammalian cells.43
Although chitosan has good biocompatibility and antibacter-
ial activity,44 its physical properties are highly pH
dependent.45 To overcome the poor solubility, water soluble
oligochitosan has been made by hydrolysis of chitosan.46
However, the yields of oligochitosan were often low and
lead to a mixture of products.46,47 Moreover, since chitin is
sourced from shellfish, and chitosan and oligochitosan are
derivatives of chitin, their use may not be appropriate for
people with shellfish allergies.48 Compared to these poly-
mers, the positively charged spider silk protein eADF4(κ16)
has several advantages, including good biocompatibility, low
immunogenicity, nontoxicity, and biodegradability.49–54
Recombinant spider silk protein eADF4(κ16) is a variant of
polyanionic eADF4(C16), where the naturally occurring glu-
tamic acid residue in the sequence of the eADF4
core C-module (GSSAAA AAAAAS GPGGYG PENQGP
SGPGGYGPGGP) is replaced with lysine.49 eADF4(C16) is
based on the consensus core sequence of the garden spider
Araneus diadematus dragline silk fibroin 4 (ADF4) and
comprises a consensus (C) module repeated 16 times.55
Importantly, both recombinant spider silk proteins have
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similar physiochemical properties and therefore can be pro-
cessed into several morphologies like particles, films, coat-
ings, and fibers.56 These properties show that recombinant
spider silk can be used as a suitable biopolymer to modify the
surface charge of nanoparticles to enhance their antibacterial
activity.
In this work, the positively charged spider silk pro-
tein eADF4(κ16) was selected to stabilize Se NPs and
provide a net positive surface charge. Se NPs coated
with the positively charged eADF4(κ16) were expected
to show increased interactions with negatively charged
bacterial cell membranes. Their antibacterial properties
against Gram-negative bacteria, such as E. coli, and
cytotoxicity for mammalian cells were assessed. In addi-
tion, PVA coated Se NPs were studied in comparison to
the eADF4(κ16)-coated NPs. PVA is a commonly used
stabilizing agent for Se NPs,57,58 and the antibacterial
activity of PVA coated Se NPs have been investigated in
many studies.9,23,35,59 Furthermore, the eADF4(κ16)-
coated NPs were immobilised on positively or negatively
charged spider silk protein films, and their ability to
exert their antibacterial activity was assessed.
Materials and Methods
Materials
Selenium dioxide (SeO2, 98%), PVA (MW 9000–10000, 80%
hydrolysed), formic acid (≥98%) and Mueller-Hinton broth
were purchased from Sigma Aldrich (Germany). L-ascorbic
acid (≥99%) and agar was obtained from Roth Carl Roth
GmbH (Germany). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP,
99+%) was purchased from Alfa Aesar (Germany). Dimethyl
sulfoxide (DMSO, ≥99.5%) was bought from Fluka
(Australia). Phosphate-buffered saline (PBS) tablets were
bought from Gibco (UK). In all the experiments, ultrapure
water from a Milli-Q-system (Billerica, MA, USA) was used.
Proteins: eADF4(C16) was purchased from AMSilk
GmbH (Planegg/München, Germany). eADF4(κ16) was
produced and purified as described previously.49,55
Se NPs Synthesis
For fabrication of positively charged Se NPs, the recom-
binant spider silk protein eADF4(κ16) was first dissolved
in formic acid (≥98%) at a concentration of 4 mg/mL and
further diluted with water to obtain a concentration of
0.1 mg/mL. SeO2 powder was added into this solution to
a concentration of 5 mM. Then, 4 mL of 0.1M L-ascorbic
acid was added into 4 mL of 0.1 mg/mL eADF4(κ16) and
5 mM SeO2 solution. The reaction mixture was stirred at
a speed of 300 rpm using a magnetic stirrer. After 10 min,
the solution was transferred into 2 mL Eppendorf tubes
and was centrifuged at a speed of 13,300 rpm (17,000 g)
for 3 min using a Heraeus Pico 17 centrifuge (Thermo
Scientific), followed by removal of supernatant and wash-
ing the particles twice with water. Particles were stored in
water for all experiments. Similarly, negatively charged Se
NPs were fabricated using PVA dissolved in water at
a concentration of 2 mg/mL.
Characterization of Se NPs
The zeta potential of Se NPs was measured using a Zetasizer
(Malvern, ATA Scientific). Zeta potential was measured at
25°C; selenium with a refractive index (RI) of 2.6 and
absorption of 0.5 was set as the material, a dielectric constant
of 78.5 for water as the dispersant.60 The morphology of the
Se NPs was observed using transmission electron micro-
scopy (TEM, JEOL, Japan) at an accelerating voltage of 80
keV. The particle sizes were determined by measuring 200
nanoparticles from more than 4 TEM images of each sample
in different areas. Energy Dispersive Spectroscopy (EDS)
within an equipped-on scanning electron microscope (SEM,
Zeiss Sigma 300 VP, Oberkochen, Germany) was used to
detect the component elements of the nanoparticles. The
interaction between Se NPs and eADF4(κ16) or PVA was
investigated by measuring their Attenuated Total Reflection-
Fourier Transform Infrared (ATR-FTIR) Spectra in the range
of 4000–800 cm−1 on a Bruker Tensor 27 spectrometer
(Bruker, Germany). For each spectrum, 100 scans were
recorded at a resolution of 4 cm−1. The individual secondary
structure elements were determined by analysing the amide
I region (1595–1705 cm−1) with Fourier self-deconvolution
(FSD) using Opus software (Bruker, Germany). To measure
the Se concentration of the Se NPs solutions, nitric acid
(HNO3) was used to dissolve the Se NPs into ions, and ICP-
OES (Perkin Elmer Optima 7300 DV, USA) was adopted to
test the Se ion concentrations.
Cytotoxicity Tests of Se NPs
AlamarBlue® was used to test the cytotoxicity of Se NPs.
Balb/3T3 mouse embryo fibroblasts and HaCaT human skin
keratinocytes (European Collection of Cell Cultures) were
used to evaluate the cytotoxicity of Se NPs. The cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum (FBS), 100 U·mL−1 gentamy-
cin and 100 μg·mL−1 glutamine, 5% CO2, 95% relative
humidity, and at 37°C.
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Se NPs solution at a concentration of 500 µg/mL in
water was serially diluted with DMEM from concentra-
tions of 0.97 to 31.2 µg/mL. The control groups comprised
DMEM medium as the negative control and DMEM with
10% (v/v) DMSO as the positive control, according to ISO
10993–5 standard.61 Cells at a density of 5×103 per
100 μL medium per well were added into the 96-well
plates and incubated for 24 h at 37°C to allow attachment.
The medium was then replaced by 100 μL of DMEM with
Se NPs or control media. After 24 h incubation, the
DMEM with Se NPs was removed and washed once by
PBS. Then, 120 μL of DMEM with 10% alamarBlue®
reagent was added to all wells and incubated at 37°C.
After an incubation time period of 3 h, 100 μL medium
was transferred from each well to a black 96-well plate.
The transformation of the blue fluorescent dye resazurin
into red fluorescent resorufin (λex= 530 nm; λem= 590
nm) was measured using a plate reader (Mithras LB 940,
Bertold, Bad Wildbach, Germany) with 530 nm excitation
and 600 nm emission filters and a counting time of 0.5
s. The cell viability (X) of each experimental group was
calculated based on three samples using the formula below
according to ISO 10993–5.61
X ¼ ðOD1  ODbÞðOD2  ODbÞ  100% (1)
where OD1 represents the mean fluorescence density of the
experimental groups or the positive control group, OD2
represents the mean fluorescence density of the negative
control group, ODb represents the mean fluorescence den-
sity of the blank control.
Antibacterial Tests of Se NPs
Colony-forming units (CFU) assays using Escherichia coli
(E. coli, strain BL21-Gold, Novagen, Merck, Germany)
were performed for testing the antibacterial activity of Se
NPs and the particles made of plain eADF4(κ16). Firstly,
a single colony of E. coli taken from an agar plate was
inoculated into 20 mL Mueller Hinton Broth (MHB) and
was cultured overnight at 37°C. Then 200 µL of the over-
night bacterial solution was transferred into 10 mL fresh
MHB and cultured for 4h at 37°C. 100 µL of water with
different concentrations of Se NPs or plain eADF4(κ16)
particles was added into each well of 96-well plates. The
bacteria were centrifuged at 13,300 rpm (17,000 g) for
15 min, then washed using water once and resuspend
into water. 100 µL of 1×107 cells/mL of E. coli in water
was added into each well. After 4 h incubation at 37°C, the
bacterial suspensions were diluted to 10−1, 10−2, 10−3 and
10−4 times with water, then 10 µL of these solutions were
transferred to agar plates with MHB. The agar plates were
incubated overnight at 37 °C, then the bacterial colony
forming units were observed and counted. The minimum
bactericidal concentration (MBC) was calculated accord-
ing to the method published previously62. Concentration-
killing curves were plotted with CFUs/mL as a function of
antibacterial agent concentration, and linear regression
analysis was used to determine the lowest concentration
(MBC) at which the CFU/mL becomes zero.
Bacterial Morphology Imaging
The morphology of E. coli cells after treatment with Se
NPs was imaged using SEM (Zeiss Sigma 300 VP,
Oberkochen, Germany). The samples were prepared as
follows: 100 µL of 150 µg/mL Se NPs in water was
added into each well of 96-well plates, then 100 µL
MHB with 5×107 cells/mL bacteria was added into each
well. After 2 h incubation, 10 µL of the bacteria with Se
nanoparticles solution was dropped onto a clean silicon
wafer, followed by drying at 37°C for 40 min. Afterwards,
2.5% v/v glutaraldehyde was used to fix the bacteria cells
for 1 h, then gradient ethanol solutions (30%, 50%, 60%,
70%, 80%, 90%, 95% and 100% v/v) were used for
dehydration. After overnight drying in the air, the samples
were coated with platinum prior to imaging.
Fabrication of eADF4(κ16)-Coated Se
NPs Immobilized on Spider Silk Protein
Films
To prepare films, recombinant spider silk proteins eADF4
(κ16) or eADF4(C16) were first dissolved in HFIP to
a concentration of 30 mg/mL, and 10 µL of the solution
was dropped into each well of a 48-well plate. The samples
were allowed to dry inside a fume hood and were post-treated
with 70% ethanol to induce β-sheet formation.63,64 Then,
10 µL of eADF4(κ16)-coated Se NPs at a concentration of
3 mg/mL in HFIP was quickly dropped onto the films and
allowed to dry in a fume hood. All the films were sterilized
by UVexposure for 1 h.
Antibacterial Tests of Se NPs Immobilized
on Spider Silk Protein Films
CFU assays on E. coli were performed for testing the anti-
bacterial activity of Se NPs immobilized on spider silk
protein films. Firstly, a single colony of E. coli taken from
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an agar plate was inoculated into 20 mL MHB and was
cultured overnight at 37°C. Then, 200 µL of the overnight
bacterial solution was transferred into 10 mL fresh MHB
and cultured for 4 h at 37°C. 250 µL of 1×106 cells/mL of
E. coli in MHB was added into a 48-well plate with films
and incubated for 4 h. The later steps for diluting the bacteria
suspensions and culturing colonies on agar plates were the
same as those used for CFU assays on Se NPs.
Releasing Tests of Se NPs Immobilized on
Spider Silk Protein Films
Adhesive force between particles and substrates can be
assessed qualitatively65 or quantitatively.66,67 However,
for release measurements several additional factors besides
simple adhesion should be taken into account, such as the
flow fluids across the surfaces. Therefore, a more praxis-
related technique, as described below, was used in this
work which simulated the in vivo conditions to qualita-
tively analyze the release properties.
The eADF4(κ16)-coated Se NPs immobilized on eADF4
(κ16) films or eADF4(C16) films were fabricated into
a 48-well plate, as mentioned above. For each type of films,
250 µL of MHB was added into each well of six sample wells
and incubated at 37°C for 4 h. In three of these six sample
wells, 150 µL of MHB was directly taken from each well and
transferred to a 10 mL centrifuge tube. For the other three
samplewells, 150µLofMHBwas taken after 5 times pipetting
from the surface of films using a 1 mL pipette (Eppendorf®
Research® Plus) and transferred to a 10 mL centrifuge tube.
350 µL HNO3 was added into each of the centrifuge tubes and
allowed to react overnight to dissolve the Se NPs. Then, the
solution was diluted using water and analysed by inductively
coupled plasma-optical emission spectrometry (ICP-OES,
Varian 720-ES) to determine the Se ion concentrations.
Statistical Analysis
Data in this work are expressed as means ± standard devia-
tion of three measurements. Statistical analyses for all results
were performed by one-way analysis of variance (ANOVA
with Tukey’s Post Hoc Test using SPSS 25.0) and p-values
less than 0.05 were considered statistically significant.
Results and Discussion
Synthesis and Characterization of
Selenium Nanoparticles
Selenium nanoparticles (Se NPs) were synthesized by che-
mical reduction of selenous acid, obtained by adding
selenium dioxide in water. eADF4(κ16) and polyvinyl alco-
hol (PVA) were used as stabilizing agents and L-ascorbic
acid as reducing agent. TEM images of different sized Se
NPs are shown in Figure 1A-B. These nanoparticles were
all spherical and quite monodisperse, indicating that both
eADF4(κ16) and PVA are good stabilizers for Se NPs
yielding a stable surface coating. The size distribution of
these nanoparticles evaluated from their TEM images is
shown in Figure 1C-D. The mean diameter of Se NPs
stabilized with 0.1 mg/mL eADF4(κ16) (46 nm) matched
that of 2 mg/mL PVA stabilized Se NPs (46 nm). The zeta
potentials of the eADF4(κ16)-coated Se NPs and PVA
coated Se NPs were +46.0 ± 0.6 mV and −7.3 ± 0.1 mV,
respectively. The zeta potential distributions are shown in
Figure S1.
Energy Dispersive Spectroscopy (EDS) analysis of
eADF4(κ16)-coated Se NPs is shown in Figure S2A.
Peaks corresponding to O, N and Se confirm the eADF4
(κ16) coating of the Se NPs. Also, EDS of control samples
was measured, prepared by washing the eADF4(κ16)-
coated Se NPs with guanidinium thiocyanate, as shown in
Figure S2B. Guanidinium thiocyanate denatures the protein
structure of the eADF4(κ16) coating, which is thereby
removed from the Se NP surface, leading to aggregation
of Se NPs and disappearance of the nitrogen peak in the
EDS. The eADF4(κ16)-coated Se NPs were observed visi-
bly to be stable in water for more than 3 months, indicating
that the coating made of eADF4(κ16) on the Se NPs was
stable, preventing particle aggregation.
FT-IR was used to investigate the structural features of Se
NPs and eADF4(κ16), and the spectra are shown in Figure 1E.
eADF4(κ16)-coated Se NPs showed very similar spectra to
that of plain eADF4(κ16) particles used as controls. After
washing with guanidinium thiocyanate, the protein peaks of
the coated Se NPs significantly decreased. Fourier self-
deconvoluted absorbance spectra of the amide I band of
eADF4(κ16) particles and eADF4(κ16)-coated Se NPs were
evaluated and are shown in Figure S3. The percentages of the
secondary structure elements are listed in Table 1. Comparing
to eADF4(κ16) particles, eADF4(κ16)-coated Se NPs showed
similar features with a slightly decreased percentage of side
chains and increased percentage of turns.
FT-IR was also used to investigate the structural fea-
tures of Se NPs coated with PVA (Figure 1F). Plain PVA
showed a peak at 3307 cm−1 corresponding to
O-H stretching vibrations. The peaks at 2850 cm−1,
2920 cm−1 and 2941 cm−1 corresponded to
C-H stretching from the alkyl group. In comparison,
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Figure 1 TEM images and the corresponding size distributions of Se NPs coated with (A, C) eADF4(κ16), and (B, D) PVA. Inset images inside (A, B) are high resolution
images. FT-IR spectra of Se NPs coated with (E) eADF4(κ16), and (F) PVA and comparisons with control spectra of eADF4(κ16) and PVA.
Huang et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
International Journal of Nanomedicine 2020:154280
PVA coated Se NPs showed a shift in the hydroxyl peak
to 3369 cm−1. This blue-shift indicated that PVA was
conjugated to the surface of Se NPs through the –OH
group.36
Cytotoxicity Test of Selenium
Nanoparticles Using Fibroblasts and
Keratinocytes
The cell viability of Balb/3T3 mouse embryo fibroblasts and
HaCaT human skin keratinocytes exposed to different concen-
trations of eADF4(κ16)-coated Se NPs and PVA coated Se
NPs were measured using the alamarBlue® assay (Figure 2).
Balb/3T3 mouse embryo fibroblasts are frequently used to test
materials’ carcinogenicity68 and cytotoxicity,69,70 and HaCaT
keratinocytes are a preliminary in vitro model to investigate
skin toxicity.71 Both of these cell lines have been widely used
for cytotoxicity tests of nanoparticles.70,72-74 The PVA coated
Se NPs exhibited no obvious cytotoxicity at concentrations up
to 31.2 µg/mL. The viability of Balb/3T3 mouse embryo
fibroblasts did decrease somewhat with increasing concentra-
tions of Se NPs, but their viability was not below 70% even at
the highest dose of 31 µg/mL (one-sample t-test, p=0.41).
According to ISO 10993–5,61 a material reducing cell viability
below 70% of the negative control is considered to be poten-
tially cytotoxic, so the effects of these Se NPs would not
be classified as cytotoxic at these doses. All in all, up to
31 µg/mL, eADF4(κ16)-coated Se NPs and PVA coated Se
NPs were not considered to be potentially cytotoxic for Balb/
3T3 mouse embryo fibroblasts.
After 24 hours’ exposure, both the eADF4(κ16)-coated Se
NPs and the PVA coated Se NPs showed no significant cyto-
toxicity to the HaCaT human skin keratinocytes at doses up to
31.2 µg/mL. The viability of HaCaT human skin keratinocytes
exposed to PVA coated Se NPs showed a trend of first
Table 1 Percentages of Secondary Structure Elements of eADF4
(κ16) and eADF4(κ16)-Coated Se NPs Based on the Fourier Self-
Deconvoluted Absorbance Spectrum of the Amide I Band
Samples Percentage of Secondary Structure Elements (%)
Side
Chains
β-Sheets Random
Coils
α-Helices Turns
eADF4(κ16)
particles
5 ± 1 41 ± 1 24 ± 1 7 ± 1 22 ± 1
eADF4(κ16)-
coated Se NPs
2 ± 1 39 ± 2 25 ± 1 9 ± 1 26 ± 1
Figure 2 Effects of Se NPs on the viability of mammalian cells in culture. Balb/3T3 mouse embryo fibroblasts incubated with (A) eADF4(κ16)-coated Se NPs, and (B) PVA
coated Se NPs; HaCaT human skin keratinocytes incubated with (C) eADF4(κ16)-coated Se NPs, and (D) PVA coated Se NPs for 24 h, at 37 °C. One-way ANOVA with
Tukey’s post hoc test was used to compare means of experimental groups to that of the negative control group, **p-value < 0.01, ***p-value < 0.001. The dashed horizontal
line represents 100% viability, and the solid line represents 70% viability.
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increasing to 153±12%with 3.9 µg/mL of PVA coated Se NPs
and then decreasing with increasing Se concentrations. This
trend, which is consistent with our previous findings,23 may be
attributed to the antioxidant activity of Se NPs.16,75 At low
levels, Se cannot sufficiently scavenge reactive oxygen species
(ROS), whereas at high levels, Se can catalyse the production
of ROS, which can be toxic to human cells, making an inter-
mediate dose favourable. The eADF4(κ16)-coated Se NPs did
not show this trend, possibly due to differences in their inter-
actions and uptake by the cells. As selenium has a very low
solubility in physiological conditions, the ways the NPs them-
selves interact with the cells are expected to govern their
effects.
The greater decrease in the viability of the Balb/3T3
mouse embryo fibroblasts with the eADF4(κ16)-coated Se
NPs compared to the PVA coated Se NPs may be ascribed to
the surface charge of the Se NPs. High positive surface
charge of NPs has been reported to be more cytotoxic than
negative surface charge.76 The cellular uptake process can be
divided into two steps: first, particles attach to the cell mem-
brane, and second, they are internalized by the cells.77 The
step of attachment is mostly affected by the surface charge of
the nanoparticle.78,79 As the cell membrane is dominated by
negatively charged sulphated proteoglycans,80 nanoparticles
with high positive surface charge can therefore more easily
approach cells and become strongly bound to the cell mem-
brane, resulting in a higher cellular uptake.81 As the eADF4
(κ16)-coated Se NPs have a high positive surface charge
(+46.0 ± 0.6 mV), they may induce higher cellular uptake
resulting in greater effects on the cells. The PVA coated Se
NPs have a slightly negative surface charge (−7.3 ± 0.1 mV),
which may reduce their ability to be taken up by the cells,
consistent with them being less cytotoxic.
Antibacterial Activity of Selenium
Nanoparticles
eADF4(κ16)-coated Se NPs and PVA coated Se NPs were
tested for their antibacterial activity against E. coli as a model
organism. Both types of Se NPs showed dose-dependent anti-
bacterial effects against E. coli (Figure 3A). However, the
bactericidal effect of eADF4(κ16)-coated Se NPs was much
higher than that of its counterpart, with aminimumbactericidal
concentration (MBC) against E. coli of 8 ± 1 µg/mL, which is
50 times lower than that of the PVAcoated SeNPswith aMBC
of 405 ± 80 µg/mL. Figure 3B-D shows the agar plates with
E. coli colonies after treatment with Se NPs. It could be clearly
shown that no colonieswere detectedwhen treatedwith at least
15.6 µg/mL of eADF4(κ16)-coated Se NPs. By contrast,
a large number of colonies appeared even after treatment
with 31.2 µg/mL of PVA coated Se NPs. As shown above,
eADF4(κ16)-coated Se NPs are safe for both Balb/3T3 mouse
embryo fibroblasts and HaCaT human skin keratinocytes up to
31 µg/mL, which is much higher than theMBC (8 ± 1 µg/mL)
of these NPs against E. coli. Therefore, it should be safe and
effective to use these particles at doses below 31 µg/mL for
antibacterial applications. However, further testing would be
needed to confirm their biocompatibility for specific in vivo
applications.
Themorphologies ofE. coli before and after treatmentwith
the Se NPs are shown in Figure 3E-G. The negatively charged
PVA coated Se NPs were repelled by E. coli (Figure 3F),
whereas the eADF4(κ16)-coated Se NPs were able to attach
to E. coli (Figure 3G). The greater attachment of the Se NPs
with the positively charged coating to E. coli correlates well
with the lower concentration of these NPs required to show
antibacterial efficacy, as demonstrated in Figure 3A. These
results confirmed the importance of electrostatic attraction
between positively charged nanoparticles and negatively
chargedmembrane of bacterial cells for the antibacterial activ-
ity of nanoparticles.26,82
Particles made of plain eADF4(κ16) alone showed no
antibacterial effects up to 250 µg/mL against E. coli
(Figure S4), so the antibacterial activity of the eADF4
(κ16)-coated Se NPs can be primarily attributed to their
selenium content. Our previous work revealed that Se
NPs show multi-modal mechanisms of action on Gram-
positive bacteria, including depletion of internal adeno-
sine triphosphate (ATP), promotion of ROS production,
and disruption of membrane potential.23 ATP is an
important energy source of living organisms, the deple-
tion of ATP can seriously affect both respiration and
metabolism of bacteria.83,84 Over production of ROS
can induce the damage of cellular components including
lipids, DNA and proteins.85,86 Disruption of membrane
potential can cause changes of a series of cellular
processes.87 Chudobova et al also found that Se NPs
could impair the bacterial DNA structure of the zntR
gene amplified in vitro88 and Liu et al reported that Se
NPs could weaken bacterial membranes and decrease the
function of adhesion-mediating proteins.89 Tran et al
proposed that the antibacterial effect of Se NPs is also
related to free intracellular thiol depletion of Se NPs.90
Besides, the positive charge could enhance the interac-
tions between NPs and cell membranes, and then induce
more intense membrane damage,91 which can also be an
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antibacterial mechanism of eADF4(κ16)-coated Se NPs.
Further studies would be needed to elucidate the specific
mechanisms of action of eADF4(κ16)-coated Se NPs.
In a previous study, PVA coated Se NPs with effective
antibacterial activity against Gram-positive bacteria
S. aureus were fabricated.23 However, these particles were
found to be less effective against the Gram-negative bac-
teria E. coli. In the present work, the eADF4(κ16)-coated Se
NPs showed a much higher antibacterial activity against
E. coli than PVA coated ones. Meanwhile, these particles
also retained good antibacterial activity against S. aureus
(Figure S5), with a MBC value of 32 ± 1 µg/mL. Notably,
the MBC of eADF4(κ16)-coated Se NPs against E. coli was
four times lower than that against S. aureus. Positively
charged NPs often work better against Gram-negative bac-
teria than Gram-positive bacteria as the Gram-negative
bacteria are more sensitive to positively charged
materials.92,93 The antibacterial activity of these eADF4
Figure 3 (A) colony-forming units (CFU) assay using E. coli after treatment with eADF4(κ16) and PVA-coated Se NPs with varying concentrations from 3.9 µg/mL to 250 µg/
mL. One-way ANOVA with Tukey’s post hoc test was used to compare means of experimental groups at each concentration, *p-value < 0.05. (B–D) Agar plate images of
CFU test of E. coli, (B) control without particles, (C) PVA coated Se NPs, (D) eADF4(κ16)-coated Se NPs. 10° is the original (bacteria + Se NPs) solution, 10−1, 10−2, 10−3
and 10−4 mean diluting the original solution 10, 100, 1000 and 10,000 times, respectively, to make the colonies more countable. SEM images of 2.5 ×107 cells/mL E. coli before
and after treatment with 75 µg/mL Se NPs: (E) plain E. coli, (F) E. coli incubated with PVA coated Se NPs, and (G) E. coli incubated with eADF4(κ16)-coated Se NPs.
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(κ16)-coated Se NPs is very high compared to previously
reported PVA coated Se NPs, which normally show
a minimum inhibitory concentration (MIC) higher than 60
µg/mL9,17,34,35 against S. aureus, and even worse perfor-
mance against E. coli, with no significant effect,9,24,25,35 or
MIC values higher than 100 µg/mL.17,34,94 Although the
MBC was not tested in most of these studies, the MBC is
generally higher than the MIC. By contrast, the eADF4
(κ16)-coated Se NPs showed relatively low MBC values
of 32 ± 1 µg/mL against S. aureus, and 8 ± 1 µg/mL against
E. coli. The PVA coated Se NPs showed a MBC of 35 ± 16
µg/mL against S. aureus,23 but they were found to have only
weak antibacterial effects against E. coli as mentioned
above. One study showed Se NPs with MIC of 4 µg/mL
against both S. aureus and E. coli.95 However, this required
additional antimicrobial compounds to boost the efficacy of
Se NPs. Although the eADF4(κ16)-coated Se NPs showed
higher antibacterial activity than previously reported Se
NPs, it is worth noting that the antibacterial tests of these
eADF4(κ16)-coated Se NPs were conducted in water rather
than bacterial culture medium as used for other studies due
to the tendency of the eADF4(κ16)-coated Se NPs to aggre-
gate in bacterial culture medium.
Antibacterial Test of Spider Silk Coated
Se NPs Immobilized on Spider Silk Films
The eADF4(κ16)-coated Se NPs were found to quickly
aggregate and deposit in Mueller-Hinton broth (MHB).
MHB is a nutrient-rich medium, which is representa-
tive of the physiological environment96 and regarded to
be the gold standard culture media for antibacterial
susceptibility testing.97,98 Thus, in order to stabilize
the particles against aggregation in MHB, they were
immobilized on the surfaces of films made of the
positively charged eADF4(κ16) and negatively charged
eADF4(C16). Physicochemical properties as well as
secondary structure of spider silk films have been thor-
oughly characterised in previous studies.64,99 Then, the
antibacterial activity of the immobilized Se NPs was
tested. The charge of the films was expected to influ-
ence both the immobilization and potential release of
the eADF4(κ16)-coated Se NPs.
The CFU test results for E. coli after treatment with
eADF4(κ16)-coated Se NPs immobilized on the two types
of spider silk protein films are shown in Figure 4A.
eADF4(κ16)-coated Se NPs immobilized on eADF4(κ16)
films (with the identical surface charge) showed
a significant antibacterial activity, whereas particles on
eADF4(C16) films (with the opposite surface charge)
showed no significant difference in CFU counts relative
to the control.
These results demonstrated the effect of the charge
of the surface used to immobilize the coated Se NPs.
The positively charged eADF4(κ16)-coated Se NPs
would be expected to adsorb more strongly to the nega-
tively charged eADF4(C16) films through electrostatic
interactions than to the positively charged eADF4(κ16)
films. This was confirmed by comparison of the amounts
of Se released from the two types of films with immo-
bilized eADF4(κ16)-coated Se NPs (Figure 4B). Very
little Se was released from the films after 4 h under
static immersion in MHB. Upon applying gentle shear
Figure 4 (A) CFU test results of E. coli after treatment with 46 nm eADF4(κ16)-coated Se NPs immobilized on eADF4(κ16) or eADF4(C16) films. (B) The Se
concentrations released from films after 4 h static immersion in MHB or 4 h static immersion in MHB with 5 times pipetting on the surface of the films. One-way
ANOVA with Tukey’s post hoc test was used to compare means of experimental groups, ***p-value < 0.001.
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forces via pipetting, the positively charged eADF4(κ16)
films released significant amounts of selenium into the
culture broth, however, no significant release was seen
from negatively charged films. Thus, the Se NPs could
be more easily released from the eADF4(κ16) films, and
this correlates with the lower CFU counts found for
E. coli exposed to these films. This indicates that these
Se NPs need to be released from the spider silk surface
in order to exert their antibacterial effects on E. coli.
Besides, unlike Ag NP coatings which could rely on the
released silver ions to provide the antibacterial
activity,100 the present work implied that Se NP coatings
need to rely on NPs themselves to combat bacteria
rather than operating via the release of selenium ions.
This correlates well with the much lower solubility of
selenium compared to that of silver.100,101 These new
insights will help enable the future design of effective
antibacterial surface coatings based on Se NPs.
Conclusion
Previous studies have reported that negatively charged Se
NPs showed good antibacterial activity against Gram-
positive bacteria, but they are less effective against Gram-
negative bacteria which are more sensitive to positively
charged nanoparticles. In this work, positively charged
eADF4(κ16)-coated Se NPs and negatively charged PVA
coated Se NPs with the same mean diameter (46 nm) were
fabricated. Both the eADF4(κ16)-coated Se NPs and PVA
coated Se NPs were safe to Balb/3T3 mouse embryo
fibroblasts and HaCaT human skin keratinocytes up to
31 µg/mL. Comparing to PVA coated Se NPs, eADF4
(κ16) stabilized Se NPs showed a much higher bactericidal
efficacy against the Gram-negative bacteria E. coli.
Particularly, the MBC of eADF4(κ16)-coated Se NPs (8
± 1 µg/mL) was approximately 50 times lower than that of
PVA coated Se NPs (405 ± 80 µg/mL). Immobilizing the
eADF4(κ16) stabilized Se NPs on positively charged
eADF4(κ16) films showed a good bactericidal effect
against E. coli in culture broth. Together, these results
indicated that eADF4(κ16)-coated Se NPs can be consid-
ered as promising new antibacterial agents.
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